Xtant Medical Engages in Significant Musculoskeletal Conference in New Orleans

Overview

Xtant Medical Holdings, Inc., a renowned global player in medical technology, has announced its participation in the upcoming Canaccord Genuity 2026 Musculoskeletal Conference. Set to unfold on March 2, 2026, this event will be hosted both in New Orleans and virtually, showcasing the company’s latest advancements in surgical solutions for orthopedic care.

Event Details

In a move that emphasizes its commitment to innovation and collaboration within the healthcare sector, Xtant Medical’s leadership team will include key figures: Sean Browne (CEO), Scott Neils (CFO), and Mark Schallenberger (COO). They will present insights on the company’s strategic initiatives and product offerings aimed at improving patient outcomes in spinal and orthopedic care placements.

Participants interested in the conference can access a live webcast of the Xtant Medical presentation starting February 2 at 2:00 PM ET. Additionally, the management team will offer virtual one-on-one meetings with interested investors that day, a significant opportunity for networking and further inquiries about Xtant's expanding portfolio. Those wishing to review the recorded presentation will find it accessible on Xtant Medical's Investor Relations website, which will be available for 90 days following the conference.

About Xtant Medical Holdings, Inc.

Founded with a mission to honor the gift of organ donation, Xtant Medical is dedicated to providing surgical solutions that allow patients to lead fulfilling lives following treatment for various medical conditions. The company specializes in a comprehensive range of orthobiologics tailored for chronic and surgical wound care, as well as offering spinal implant systems. With a strong commitment to integrity and service, Xtant Medical aims to positively impact the healthcare landscape. The company’s innovative technologies and products cater specifically to the demands of today’s surgical environment, reflecting their ongoing dedication to medical excellence.

Upcoming Innovations and Developments

With a focus on musculoskeletal health, Xtant continues to push boundaries by examining the latest advancements in product design and patient safety measures. As the healthcare sector grapples with evolving challenges, Xtant Medical’s strategic presence at key industry events like the Canaccord Genuity conference solidifies its role as a leader in surgical solutions.

This conference is not just a platform for showcasing technologies but also serves as a nexus for discussion around the future of surgical practices within the musculoskeletal domain. The company aims to gather insights and perspectives from various stakeholders, which could inform future innovations and enhance treatment standards across the board.

Conclusion

Xtant Medical's active engagement in the Canaccord Genuity 2026 Musculoskeletal Conference illustrates their proactive approach in fostering collaboration and sharing knowledge within the industry. As they prepare to unveil new strategies and solutions during the conference, the company symbolizes a forward-thinking attitude in addressing critical medical challenges and sustaining growth in the highly competitive healthcare landscape.